2018, 131 postmenopausal women, 12-month RCT - is genuine and positive
The arrival of oral GLP-1 therapies marks the beginning of a new chapter in obesity pharmacotherapy.
According to the available research, such as experiments by Bowers et al., GHRP-2 may also upregulate growth hormone synthesis by pituitary cells
GLP-1 drug's sole action is to slow digestion
Over 139,000 peer-reviewed scientific articles have addressed this powerhouse molecule, and experts are now recognizing that an alarming rate of people are deficient for a variety of reasons, including chronic stress, environmental toxins and excessive use of antibiotics
Transition plan to insulin / discontinuing GLP-1 RA